NREP
NEW REPRESENTATIVE AT IB RECEIVED
26/05/2024
Voltar para busca
Dado oficial do USPTO
STOCKHOLM3
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
STOCKHOLM3
ST13
US500000079317755Classe
5, 9, 10, 42, 44
Pedido
79317755
Registro
6854609
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
10/01/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10, 42, 44
Data de depósito
09/02/2021
Data de registro
27/09/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/09/2022
Última transação
10/01/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
SE
Examinador
BERLIN, JUSTIN
Unidade examinadora
N70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
A3P Biomedical AB
Representantes
Sarah J. Schneider Sheridan Ross P.C.
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medical and veterinary preparations and articlesdiagnostic blood test for risk stratification of prostate cancer; diagnostic preparations and materials for medical use; reagents for use in diagnostic tests for medical purposes; diagnostic testing materials for medical usemedical diagnostic reagents and medical diagnostic assays for testing body fluids for determining the presence of certain protein and genetic markers; diagnostic test materials for prostate cancermedical diagnostic reagents and medical diagnostic assays for testing body fluids for medical determination of risk stratification of prostate cancer; diagnostic preparations for medical purposes; diagnostic agents for medical use
Classe 9
Recorded computer software for supporting diagnostic testing for and determination of risk stratification of prostate cancer; recorded computer program for analysingdisplayingmodelingstratifying data from diagnostic blood tests and clinical data; instruments for diagnosis for scientific usediagnostic apparatus for testing biological specimens; parts and fittings for all the aforesaid goods included in this class
Classe 10
Medical and veterinary apparatus and instrumentsapparatus to perform a diagnostic test for risk stratification of prostate cancer; diagnosticexamination and monitoring equipment for medical usenamely apparatus for medical diagnostic testing and risk stratification in the field of prostate cancer; testing apparatus for medical purposeshuman blood and specimen testing apparatus; medical test instruments for prostate cancer; testing probes for medical diagnostic purposes; testing instruments for medical diagnostic purposes; tools for medical diagnosticsmedical diagnostic apparatuses for testing for and forecasting risk of prostate cancer; apparatus for carrying-out diagnostic tests for medical purposesmedical diagnostic apparatuses for testing of human body fluids
Classe 42
IT programming services in the nature of computer programming; software developmentprogramming and implementation; web site hosting services; Software as a service (SAAS) services featuring software for diagnostic medical testing and related data analysis; rental of computer software; providing temporary use of on-line non-downloadable software for diagnostic medical testing and related data analysis; scientific and technology servicesdiagnostic medical testing services for others for scientific research purposes; chemical and pharmaceutical research; medical and pharmacological research services; conducting clinical trials for others; scientific research for medical purposes in the area of cancerous diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information on clinical studies via an interactive website; medical and scientific laboratory services; adviceconsultancy and information relating to the aforesaidincluded in this class
Classe 44
Human healthcare services; medical services; execution of medical tests for diagnostic or treatment purposes; medical diagnostic servicesmedical testing for diagnostic or treatment purposes; health care servicesproviding diagnostic tests for prostate cancer; online services relating to medical and diagnostic prostate cancer tests in the nature of medical and health care services related to prostate cancer testing through online servicesproviding online services in the nature of website featuring informationadviceconsultation related to prostate cancer diagnostic testing; prostate cancer screening services; execution of prostate cancer tests for diagnostic or treatment purposes; health care servicesproviding prostate cancer diagnostics; medical testing services relating to prostate cancer; taking of blood samples; services for the testing of blood; performing diagnosis of diseases; medical testing for diagnostic or treatment purposes; medical services for the diagnosis of conditions of the human body; medical analysis for the diagnosis and treatment of persons; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; providing information relating to medical results and diagnostic testsprostate cancer tests; providing information relating to medical test results; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical laboratory services for the analysis of samples and blood samples taken from patients; rental of equipment for human healthcare; adviceconsultancy and information relating to the aforesaidincluded in this class
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
26/05/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/09/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/02/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
23/01/2023
FIMP
FINAL DISPOSITION PROCESSED
23/01/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/12/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
27/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
27/09/2022
GPNX
NOTIFICATION PROCESSED BY IB
18/07/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/07/2022
PUBO
PUBLISHED FOR OPPOSITION
12/07/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/06/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
29/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/06/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/06/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
21/01/2022
RFNT
REFUSAL PROCESSED BY IB
26/12/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/12/2021
RFRR
REFUSAL PROCESSED BY MPU
08/12/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/11/2021
CNRT
NON-FINAL ACTION WRITTEN
08/11/2021
DOCK
ASSIGNED TO EXAMINER
03/09/2021
MAFR
APPLICATION FILING RECEIPT MAILED
20/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/08/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace STOCKHOLM3 ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.